Virtual Precision in Drug Discovery & Preclinical Summit

October, 2020: OncoSpherix’s CEO, Dr. Margaret K. Offermann, served as Keynote Speaker and Session Chairperson in the Virtual Precision in Drug Discovery & Preclinical Summit. Her presentation was titled “Development of First-in-Class Small Molecule Dual HIF-1 and...

Semi-finalist in the AIM-HI Women’s Venture Competition

Dr Margaret Offermann, CEO of OncoSpherix, is among the 8 semi-finalist in the AIM-HI Women’s Venture Competition:  The 8 semifinalists were selected from a pool of 47 candidates from 6 countries. “The Women’s Venture Competition is one of the first venture-backed...